Scientists at Mass General Brigham have created HPV-DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity. This breakthrough could lead to earlier, less invasive treatments and significantly improve survival. A large NIH trial is underway to confirm the results.
source https://www.sciencedaily.com/releases/2025/10/251013040337.htm
Pharmaceuticals face 100% tariffs in US - unless firms strike a deal
-
The order does not affect generic medicines, the most commonly used in the
US.
source
https://www.bbc.com/news/articles/cx29kke01gpo?at_medium=RSS&at_camp...
22 hours ago
No comments:
Post a Comment